Terms: = Uterine cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
17 results:
1. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract] [Full Text] [Related]
2. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
Park SH; Hahm MH; Bae BK; Chong GO; Jeong SY; Na S; Jeong S; Kim JC
Radiat Oncol; 2020 Apr; 15(1):86. PubMed ID: 32312283
[TBL] [Abstract] [Full Text] [Related]
3. uterine Artery Embolization in Women with Symptomatic Cervical Leiomyomata: Efficacy and Safety.
de Bruijn AM; Adriaansens SJH; Smink M; Venmans A; Hehenkamp WJK; Smeets AJ; Lopez A; Huirne JAF; Lohle PNM
Cardiovasc Intervent Radiol; 2019 Mar; 42(3):371-380. PubMed ID: 30288591
[TBL] [Abstract] [Full Text] [Related]
4. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
[TBL] [Abstract] [Full Text] [Related]
5. [Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients].
Sedláková I; Laco J; Tošner J; Špaček J
Ceska Gynekol; 2015 Dec; 80(6):405-13. PubMed ID: 26741154
[TBL] [Abstract] [Full Text] [Related]
6. Management of borderline change in endocervical cells: a more dependable approach.
Kodiathodi S; Chattopadhyay S; Baldwin A; Franks P
Br J Cancer; 2014 Aug; 111(5):851-7. PubMed ID: 24967874
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of laparoscopic versus abdominal radical hysterectomy for FIGO stage IB and IIA cervical cancer with tumor diameter of 3 cm or greater.
Kong TW; Chang SJ; Lee J; Paek J; Ryu HS
Int J Gynecol Cancer; 2014 Feb; 24(2):280-8. PubMed ID: 24407571
[TBL] [Abstract] [Full Text] [Related]
8. clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Moerland MA; Witteveen PO; Schreuder HW; van Dorst EB; Jürgenliemk-Schulz IM
Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
[TBL] [Abstract] [Full Text] [Related]
9. Does the FIGO 2009 endometrial cancer staging system more accurately correlate with clinical outcome in different histologies? Revised staging, endometrial cancer, histology.
Page BR; Pappas L; Cooke EW; Gaffney DK
Int J Gynecol Cancer; 2012 May; 22(4):593-8. PubMed ID: 22343970
[TBL] [Abstract] [Full Text] [Related]
10. A clinical review of borderline glandular cells reported on liquid-based cervical cytology.
Patel A; Thampy N; Hemming D; Naik R
BJOG; 2010 Aug; 117(9):1051-9. PubMed ID: 20105162
[TBL] [Abstract] [Full Text] [Related]
11. [Assesment of selected parameters depending on the size of abdominal wall incision in patients subjected to minilaparotomy due to benign gynaecological diseases].
Malinowski A; Matyszewski A; Bartosiak-Majcher I; Wojciechowski M
Ginekol Pol; 2008 Mar; 79(3):192-7. PubMed ID: 18592854
[TBL] [Abstract] [Full Text] [Related]
12. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.
Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
JAMA; 2007 Nov; 298(19):2289-95. PubMed ID: 18029833
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome of metastatic uterine leiomyosarcoma and carcinosarcoma in a single institute.
Yoshinaga M; Togami S; Tsuji T; Fukamachi N; Kamio M; Yanagi M; Douchi T
J Obstet Gynaecol Res; 2007 Dec; 33(6):818-22. PubMed ID: 18001448
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures.
Ferrandina G; Legge F; Fagotti A; Fanfani F; Distefano M; Morganti A; Cellini N; Scambia G
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S127-32. PubMed ID: 17727936
[TBL] [Abstract] [Full Text] [Related]
15. IGF-1R expression in localized cervical carcinoma patients treated by radiochemotherapy.
Lloret M; Lara PC; Bordón E; Pinar B; Rey A; Falcón O; Molano F; Hernández MA
Gynecol Oncol; 2007 Jul; 106(1):8-11. PubMed ID: 17490736
[TBL] [Abstract] [Full Text] [Related]
16. clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy.
Chen MF; Tseng CJ; Tseng CC; Kuo YC; Yu CY; Chen WC
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1438-44. PubMed ID: 17394944
[TBL] [Abstract] [Full Text] [Related]
17. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.
Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229
[TBL] [Abstract] [Full Text] [Related]
